Status:
COMPLETED
Effect of Collagen Peptides, in Combination With Resistance Training, on Body Composition and Muscle Strength in Untrained Men
Lead Sponsor:
University of Southern Denmark
Collaborating Sponsors:
CRI Collagen Research Institute GmbH
Conditions:
Body Composition
Lean Body Mass
Eligibility:
MALE
30-60 years
Phase:
NA
Brief Summary
The effect of resistance training with post-exercise Collagen peptides (CP) supplementation on lean body mass, maximal and explosive, isometric muscle strength as well as fat mass, resting metabolism,...
Detailed Description
Participants will perform supervised resistance training involving (Leg press, pull down, chest press, back extension and abdominal crunches) 3 times a week for 12 weeks. Participants will consume eit...
Eligibility Criteria
Inclusion
- Male, between 30 and 60 years of age
- Fat mass \>25 % as measured by bioelectrical impedance analysis
- Stable weight (±5 %) and eating behaviour within the last 3 months.
- Signed informed consent
Exclusion
- Regular physical activity \>60 min / week
- Stabile or progressive diseases/conditions (including medication) contraindicating or disabling participation in intensive exercise training and/or with potential to affect training adaptation beyond normal variation. For example:
- Contraindications against physical stress corresponding guidelines of American College of Sports Medicine (ACSM)
- Subjective symptoms during exercise (e.g., unusual physical exhaustion, dyspnoea, nausea)
- Moderate to severe mobility limitation (i.e., due to rheumatic disease)
- Diagnosis of cancer within the last 5 years
- Diabetes mellitus I and II uncontrolled arterial hypertension (systolic blood pressure \>155 for mmHg and/or diastolic blood pressure \>94 mm Hg; mild hypertension under resting condition will be allowed but such participants will be recommended to consult their general practitioner).
- Conditions contraindicating the supplementation protocol.
- Contraindications against nutritional or ergogenic supplements
- Allergy/aversion against animal protein
- Liver or kidney diseases with a non-permission to ingest certain concentrations of protein.
Key Trial Info
Start Date :
September 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 23 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06061315
Start Date
September 15 2023
End Date
November 23 2024
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Department of Sports Science and Clinical Biomechanics at University of Southern Denmark
Odense, Denmark, 5000